IROCAS
Phase 3 Completed
792 enrolled
DeFianCe
Phase 2 Completed
188 enrolled
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
Phase 1 Completed
11 enrolled
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Phase 1 Completed
38 enrolled
PePiTA
Phase NA Completed
235 enrolled
Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
Phase 1 Completed
15 enrolled
A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)
Phase 1 Completed
9 enrolled
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
460 enrolled
DEBIRI
Phase 1/2 Completed
70 enrolled 10 charts
Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Phase 2 Completed
Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery
Phase 3 Completed
2,559 enrolled
1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer
Phase 2 Completed
102 enrolled
Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)
Phase 2 Completed
39 enrolled 7 charts
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
2,334 enrolled 9 charts
CUFOX
Phase 1/2 Completed
41 enrolled
SIRFLOX
Phase NA Completed
530 enrolled 14 charts
A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
Phase 1 Completed
23 enrolled
TOSCA
Phase 3 Completed
3,756 enrolled
Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer
Phase 3 Completed
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
Phase 2 Completed
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Phase NA Completed
Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
Phase 2 Completed
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
Phase 2 Completed
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan
Phase 2 Completed
40 enrolled
Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
Phase 1 Completed
Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer
Phase 1 Completed
119 enrolled
Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Phase 3 Completed
554 enrolled
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Phase 2 Completed